Alfonso Quintas Cardama
CIK 1760104 · Chief Medical Officer · last filed 2026-02-02
Alfonso Quintas Cardama is a Chief Medical Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for FHTX, was dated Feb 2, 2026. Across all open-market trades the lifetime net is −$40.3K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
17
-$40.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FHTX | Chief Medical Officer | — | $4.18 | — | $0 | 4 | 2026-02-02 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Chief Medical Officer | 0 | $1.48 | $0 | -$40.3K | 13 | 2023-06-01 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-02 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2025-01-24 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2024-01-25 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2023-09-13 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-01 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Disp (D) | −109,459 | $0 | EDGAR |
| 2022-12-19 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-13 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Sell (S) | −13,799 | -$15.1K | EDGAR |
| 2022-12-09 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Sell (S) | −7,942 | -$10.1K | EDGAR |
| 2022-12-07 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Sell (S) | −7,464 | -$10.1K | EDGAR |
| 2022-12-05 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Mixed | +91,749 | -$5.1K | EDGAR |